Trials / Completed
CompletedNCT01318382
Residual Curarization and Its Incidence at Tracheal Extubation (P08194)
Residual Curarization and Its Incidence at Tracheal Extubation
- Status
- Completed
- Phase
- Phase 4
- Study type
- Interventional
- Enrollment
- 302 (actual)
- Sponsor
- Merck Sharp & Dohme LLC · Industry
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
This study will assess the residual neuromuscular blockade (NMB) Train-Of-Four (TOF) ratios at tracheal extubation when anesthesiologists have determined that full recovery of neuromuscular function has occurred using standard clinical criteria for participants whose non-depolarizing-induced NMB is either not reversed or reversed with an acetylcholinesterase inhibitor administered as per standard routine care.
Detailed description
This is an observational cohort study with a device intervention to determine in which cohort the subject is falling.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DEVICE | TOF-Watch SX® Monitoring of NMB | Participants will have the extent of NMB monitored by a TOF-Watch SX®. |
Timeline
- Start date
- 2011-06-01
- Primary completion
- 2012-05-01
- Completion
- 2012-05-01
- First posted
- 2011-03-18
- Last updated
- 2017-05-09
- Results posted
- 2013-05-22
Source: ClinicalTrials.gov record NCT01318382. Inclusion in this directory is not an endorsement.